PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,663 stories, page 52 of 812

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07489378: NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07448610: ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07331363: Evaluation of the Effect of Using Ultrasound Robots for Breast Cancer Screening

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07210515: Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07185958: Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07072728: Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06949800: CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06747091: ARIADNE Clinical Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06686381: Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06664814: An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06541574: Prevention of ProliFerative Vitreoretinopathy With Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06489314: Mental Health Treatment to Improve Father Depression and Child Outcomes in Kenya

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06428409: A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06364774: ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06198010: A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05954793: A PMCF Study in Patients With Thoracoabdominal Aortic Aneurysms Treated With E-nside TAAA Multibranch Stent Graft System (INNER-B-APAC)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05828069: A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05696626: Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04852198: Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04784416: Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04759274: Diuretic Tuner Clinical Decision Support

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04538664: A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04402788: Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04235764: En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03367702: Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02311335: Genes Involved in Lipid Disorders

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01742299: Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01306084: Viral Infections in Healthy and Immunocompromised Hosts

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00852943: Screening Protocol for Genetic Diseases of Allergic Inflammation

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00091871: A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00023049: Genetic Analysis of Hereditary Disorders of Hearing and Balance

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00001505: The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🌍Industrybioaffinitytech.comTier 1 · Company source

Sputum-Based Test May Identify Drug Targets in Asthma and COPD – Patient Care Online

bioAffinity TechnologiesOriginal source
🌍Researchnews.uci.eduTier 2 · Direct publisher

Preparing for unpredictable precipitation with David Feldman

University of California IrvineOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Ferring bets on Gameto’s reproductive health solution through $1.38bn takeover

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US bans imports from 3 Chinese biotech companies over forced labor allegations

Ottumwa CourierOriginal source
🇮🇹Researchpoliclinico.mi.itTier 2 · Direct publisher

#CONVEGNO. [12-13.11] 4th Italian Computational Psychiatry Conference

Policlinico di MilanoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US bans imports from 3 Chinese biotech companies over forced labor allegations

Bozeman Daily ChronicleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Next-Gen Biotech: RXRX, OCGN, SNTI, VIVS, ONCO Stocks to Watch

mykxlg.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech Secures China NMPA Review for Sac-TMT and Pembrolizumab Combination in First-Line Lung Cancer

BioPharma APACOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AP report: FDA scientists opposed the Trump administration's move to ease peptides access

PBSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Geron Corporation Provides Update on Phase 3 IMpactMF Trial for Imetelstat in Myelofibrosis

Kalkine MediaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Genmab's $8B Merus bet delivers as bispecific combo halves risk of death in phase 3

Fierce BiotechOriginal source
🇺🇸universitynews.mit.eduTier 2 · Direct publisher

Capturing the complete process of embryonic development

MIT Biology NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA pilot aims to shorten residue method requirements for food-animal drugs

DVM360Original source
🌍discoverynews.google.comTier 3 · Aggregated media

US Health Secretary Kennedy opens access to some unapproved peptides

ReutersOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Phase 3 Trials at Kidney Week 2026 Show New Promise for IgA Nephropathy Care

Bioengineer.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Peptide Rush Has Begun

Time MagazineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viking Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

TradingViewOriginal source
🌍Researchuab.eduTier 2 · Direct publisher

Mental health resources for mothers available across the UAB enterprise

University of Alabama at BirminghamOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa | Eye Care Network - Modern Retina

Ophthalmology TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kennedy Opens Door to Unproven Peptide Injections

NewserOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HHS Moves to Expand Access to 6 Experimental Peptides

NewsmaxOriginal source
🇺🇸Industrythefdalawblog.comTier 3 · Secondary coverage

The PEPTIDE-L Wave Reaches HHS: Enforcement Discretion … Not the Finish Line

Hyman, Phelps & McNamara (FDA Law)Original source
🌍Industrynews.intermountainhealth.orgTier 3 · Secondary coverage

Intermountain Health Rheumatology Clinics Open to Serve Denver and Northglenn Areas

<![CDATA[Intermountain Health Newsroom]]>Original source
🇺🇸universitynews.mit.eduTier 2 · Direct publisher

Seven MIT affiliates elected to the National Academy of Medicine for 2026

MIT Biology NewsOriginal source
🇺🇸universitynews.mit.eduTier 2 · Direct publisher

How the biggest Alzheimer’s risk gene disrupts the process of insulating neurons

MIT Biology NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kodak expands pharmaceutical line with saline, new online shop

RochesterFirstOriginal source
🇦🇷Regulatoryargentina.gob.arTier 1 · Regulatory source

Autocuidado y medicamentos: ANMAT compartió sus avances en materia de modernización regulatoria ante distintas Autoridades Sanitarias de la región

ANMAT NoticiasOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kodak expands pharmaceutical portfolio with Normal Saline launch, debuts U.S. online store

Chain Drug ReviewOriginal source